Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 Next >
Eli Lilly releases new form of weight loss drug Zepbound for half the price to boost access, supply
Tags Companies Health care industry Business
From CNBC.com News
Health-care system Sesame to offer compounded versions of Wegovy through new $249 weight loss program
Tags Business News Breaking News: Business Breaking News: Technology
From CNBC.com News
Eli Lilly's weight loss drug slashes the risk of developing diabetes in long-term trial
Tags Business Health care industry Companies
From CNBC.com News
What's next for the Biden administration's Medicare drug price negotiations
Tags Companies Health care industry Business
From CNBC.com News
Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations
Tags Social issues Merck & Co Inc Novo Nordisk A/S
From CNBC.com News
Healthy Returns: Eli Lilly gains momentum against Novo Nordisk in the weight loss drug market
Tags Novo Nordisk A/S Healthy Returns Health care industry
From CNBC.com News
Digital health company Ro launches GLP-1 insurance-coverage checker to help patients navigate costs
Tags Business News Breaking News: Business Biotechnology
From CNBC.com News
Eli Lilly's Zepbound and Mounjaro now available in U.S. after shortages, FDA says
Tags US: News Eli Lilly and Co Novo Nordisk A/S
From CNBC.com News
Eli Lilly's weight loss drug Zepbound cuts heart failure risks in late-stage study
Tags Companies Health care industry Business
From CNBC.com News
Healthy Returns: Here’s what GLP-1s are being tested for beyond weight loss, diabetes
Tags Healthy Returns Health care industry Health & Science
From CNBC.com News
Older GLP-1 drug from Novo Nordisk may slow Alzheimer's disease progression by protecting the brain, study says
Tags Health care industry Business Biogen Inc
From CNBC.com News
Swiss pharma giant Roche to accelerate Wegovy rival drugs after positive trial data
Tags Pharmaceuticals Business Roche Holding AG
From CNBC.com News
Viking Therapeutics stock jumps 16% after drugmaker moves weight loss injection to late-stage trial
Tags Business Health care industry Breaking news
From CNBC.com News
Wegovy rival to be part of a suite of weight loss drugs, Roche CEO says following positive trial results
Tags Pharmaceuticals Novo Nordisk A/S Biotech and Pharmaceuticals
From CNBC.com News
Healthy Returns: The first round of Medicare drug price negotiations is nearing an end
Tags Novartis AG Health & Science Bristol/Myers Squibb Co
From CNBC.com News
Novo Nordisk's Wegovy weight loss drug wins UK approval for use as a heart treatment
Tags Health care industry Novo Nordisk A/S Health & Science
From CNBC.com News
Novo Nordisk and Eli Lilly shares slide on new obesity drug trial from Roche
Tags Pharmaceuticals Business Markets
From CNBC.com News
Healthy Returns: Diabetes drug Ozempic may lower dementia risk, nicotine use
Tags Science Novo Nordisk A/S Merck & Co Inc
From CNBC.com News
Healthy Returns: Drugmakers are racing to develop more convenient weight loss pills
Tags Healthy Returns Health care industry Novo Nordisk A/S
From CNBC.com News
Pfizer moves forward with once-daily version of weight loss pill after setbacks
Tags Pfizer Inc Eli Lilly and Co US: News
From CNBC.com News
Jim Cramer on Hims & Hers Health stock: 'I bet the business stays strong'
Tags Business News Investment Strategy Investment strategy
From CNBC.com News
FTC to sue drug middlemen over prices of medications including insulin
Tags Politics Pharmaceuticals Health & Science
From CNBC.com News
CNBC Daily Open: French left-wing shock victory, Boeing guilty plea
Tickers LAWS
Tags Interest Rates Stock markets Elections
From CNBC.com News
CNBC Daily Open: French far-right advance blocked
Tags Elections Interest Rates Stock markets
From CNBC.com News
This ETF is trying to satisfy appetites for weight loss stocks
Tags Prescription drugs Eli Lilly and Co Investing
From CNBC.com News
Novo Nordisk shares shrug off concerns over study linking weight loss drugs to rare eye condition
Tags Companies Pharmaceuticals Health & Science
From CNBC.com News
Healthy Returns: Brain implant company Paradromics launches patient registry ahead of human trial
Tags Oracle Corp UnitedHealth Group Inc Novo Nordisk A/S
From CNBC.com News
Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug data
Tags Zealand Pharma A/S Healthy Returns Health care industry
From CNBC.com News
5 things to know before the stock market opens
Tags Investing Walt Disney Co Novo Nordisk A/S
From CNBC.com News
Novo Nordisk's Wegovy weight loss drug approved in China
Tags Eli Lilly and Co US: News Novo Nordisk A/S
From CNBC.com News
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.